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Abstract
Background: Stimulated by the increasing recent use of ‘K’ or ‘rK’ nomenclature for antigens reported for visceral
leishmaniasis (VL) diagnostic serology, we wished to give a chronological synopsis of their reporting and the
potentially confusing terminology.
Methods: The literature was examined for ‘K' or ‘rK’ terminology for VL diagnostic antigens, with emphasis on the
original publications in which terms were first used.
Results: A chronological account of the first use of these 'K' and 'rK' nomenclatures was compiled. Since the original
use of this terminology in 1993 in the name rK39 for a Leishmania antigen fragment, we found nine subsequent
instances where ‘K' or ‘rK’ have been used to maintain consistency with this nomenclature. We also found instances
where there were ambiguities regarding reported strain name, origin and GenBank accession numbers.
Conclusions: We have documented here the uses in the literature of the ‘K’ or ‘rK’ prefix for VL diagnostic antigen
nomenclature. We suggest that, to avoid confusion, the use of such nomenclature for future antigens should either
provide the logical derivation of the term or indicate that the designation is entirely empirical.
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Background
We wish to clarify the potentially confusing ‘K’ or ‘rK’
nomenclature of the antigens used for visceral leish-
maniasis (VL) diagnostic serology, by giving a synopsis
of their discovery and naming. This has been stimulated
by the increasing recent use of this terminology, as
listed in Table 1. We therefore focus here on a chrono-
logical account of the first use of these nomenclatures
rather than an assessment of the use of the antigens in
serology or their native function, which are beyond the
scope of the current article. By way of introduction it is
pertinent to note that Kuhls et al. [1] demonstrated that
Leishmania chagasi, the name that had been used for
the agent of VL in South America, is synonymous with
L. infantum deriving from Europe. Thus, the term L.
infantum (syn. chagasi) will be used where appropriate.
Methods
GenBank searches of sequences homologous to the
archetypal diagnostic antigen rK39 identified publica-
tions from which the matched sequences were first
reported. Publications using subsequent novel rK no-
menclature were identified from their listing on NCBI
PubMed.
Results
In 1993, in a seminal publication, Burns et al. [2] used a
genomic library from a Brazilian strain of L. infantum
(syn. chagasi) to identify a kinesin-related gene having
high specificity and sensitivity in VL serology. A frag-
ment of this gene, encoding a 46 amino acid region
followed by 6.5 × 39 aa repeats, was expressed as a
recombinant protein in E. coli and called rK39 (Fig. 1),
where the prefix letter r stands for recombinant.
The following year, a previously identified
lipophosphoglycan-associated protein in L. donovani
entered the literature as KMP-11 (kinetoplastid
membrane protein [3]). We have included this anti-
gen in this review because it has been often reported
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in the literature, but in this case the K initial was
not given to maintain a K nomenclature.
In 1999, Alce et al. reported the identification and an-
tigenicity of two gene products, named HASPB1 and
HASPB2 (for hydrophilic acylated surface protein B),
from an Ethiopian strain of L. donovani [4]. However, in
the same year and the same journal, Bhatia et al. inde-
pendently reported the characterisation of two hydro-
philic antigens, from L. infantum (syn. chagasi), which
they named K9 and K26 [5]. There are two crucial con-
siderations regarding the description of these latter two
antigens: (i) the authors adopted the letter ‘K’ prefix in
order to maintain consistency with K39; (ii) their report
also refers to the identification in GenBank of homolo-
gous sequences from L. donovani, namely those identi-
fied by Alce and colleagues, and thus K9 corresponds to
HASPB2, and K26 to HASPB1.
In 2006 and 2007, the first kinesin sequences from
South Asian (Indian) and East African (Sudanese) L. dono-
vani (Ld) strains were reported as Ld-rKE16 and LdK39,
respectively [6, 7]. Note that the ‘KE’ in Ld-rKE16 refers
to the given strain name, and not the two-letter abbrevi-
ation for Kenya. The first two 39 amino acid repeats of
the Sudanese homologue LdK39 were later incorporated
into a synthetic gene, where they were flanked by the re-
peat sequences of HASPB1 and the whole open reading
Table 1 Chronology of the naming of ‘K’ or ‘rK’ antigens used for serological diagnosis of visceral leishmaniasis
Year Reference Antigen Species Parent protein Reported origin Strain details GenBank accession
number
1993 Burns et al. [2] rK39 L. infantum
(syn. L. chagasi)
LcKin
(kinesin-related)
Brazil MHOM/BR/82/BA-2,C1 L07879
1994 Tolson et al. [3] KMP-11 L. donovani Kinetoplastid
membrane protein
Not given LD3, derivative of
1S2D clonea
S77039a
1999 Alce et al. [4] HASPB1/
HASPB2
L. donovani HASP Ethiopia MHOM/ET/67/L28
isolate LV9
AJ011810/
AJ011809
1999 Bhatia et al. [5] K9/K26 L. infantum
(syn. L. chagasi)
Hydrophilic protein
(see text)
Brazil MHOM/BR/74/PP75 AF131227/
AF131228
2006 Sivakumar et al. [6] Ld-rKE16 L. donovani Kinesin India MHOM/IN/98/KE16 AY615886
2007 Gerald et al. [7] LdK39 L. donovani Kinesin LdK39 Sudan MHOM/SD/62/1S-CL2D DQ831678
2007 Takagi et al. [9] rKRP42 L. donovani Kinesin India/Bangladesh MHOM/IN/80/DD8 AB256033
2010 Pattabhi et al. [8] rK28 L. donovani HASPB1/LdK39/
HASPB2
Sudan/Ethiopia Synthetic gene HM594686
2013 Abass et al. [10] rKLO8 L. donovani Kinesin Sudan Lo8 KC788285
2015 Vallur et al. [11] rK18 Not given Not given Not given Not given Not given
2016 Vallur et al. [12] rKR95 L. donovani Kinesin-related
protein
Bangladesh Not applicable; see text. GI112293604
aStrain details and GenBank accession reported in [16]
Fig. 1 Schematic representations of VL diagnostic antigens with GenBank accession numbers: a rK39; b synthetic fusion rK28 and its components.
Kinesin-derived sequences are depicted in yellow shades, to indicate their different species origin; HASPB sequences depicted in green. Numbering
in bold refers to the order of the respective repeat region in the parent protein. Abbreviation: aa, amino acid
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frame of HASPB2, identified by Alce and colleagues
(Fig. 1). This new construct was named rK28, further
maintaining the letter K nomenclature of L. donovani
antigens useful in diagnostic VL serology, and the prefix
‘r’ denoting a recombinant protein [8].
The K prefix has also been used for more reported
antigens, namely rKRP42 [9], rKLO8 [10], rK18 [11] and
rKR95 [12]. rKRP42: derived from strain DD8, which
was described by the authors as being from Bangladesh
but is listed as World Health Organisation (WHO)
reference strain MHOM/IN/80/DD8 originating from
India [13, 14]. rKLO8: described by the authors as de-
riving from Sudanese strain Lo8 (lower case letter o)
without full WHO code, but a strain with WHO code
MHOM/IN/??/Lo8 [sic], had previously been reported
also with a lower case letter o but stating an Indian
origin [15]. rK18: no sequences or derivations were
given. rKR95: identified from mass spectrometry data
of Bangladeshi serum and urine and given an accession
number (see Table 1). However, searching this number in
GenBank (without the sequence identifier prefix ‘GI’) re-
trieved the entry for LdK39, which was submitted by
Gerald et al. 2007 and the sequences of which have been
used for the kinesin repeats of rK28 [7, 8].
Conclusions
Our intention here is to document the reporting of VL
diagnostic antigens using the letter ‘K’ or ‘rK’ prefix no-
menclature. We suggest that, to avoid confusion, the use
of such nomenclature for future antigens should either
provide the logical derivation of the term, for example,
indicating the origin, any known function or protein
family or that the designation is entirely empirical.
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